Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2007
04/10/2007US7202055 Preparing cells for use as bioreactors for expression of heterologous polypeptides
04/10/2007US7202054 Comprises nucleotide sequences coding transport proteins for use as tool in biological pest control; insecticides
04/10/2007US7202053 Assay determining the activity of an agent to decrease cell division; contacting protein capable of superoxide production with compound of interest and and measuring the ability of the agent to decrease superoxide production, inhibit diaphorase activity or bind the protein
04/10/2007US7202052 Regulatory protein for use in induction of nicotinamide adenine dinucleotide oxidase (NOX) for use as free radical quencher in prevention and treatment of cardiovascular and cell proliferative disorders
04/10/2007US7202046 interactions with the fluorescent ligand are then detected by means of the changes in the donor's and acceptor's excitation and/or emission energy spectra; ligands are defined as being pharmacologically significant if interaction with target protein is inhibited by the addition of non-fluorescent ligand
04/10/2007US7202044 Method for detecting a progressive, chronic dementia disease, and corresponding peptides and detection agents
04/10/2007US7202040 Method for screening compounds which change the binding properties of a protein with a ligand
04/10/2007US7202037 Electrochemical sensor using intercalative, redox-active moieties
04/10/2007US7202033 Inhibitors are identified by locking target protein kinase in inactive conformation and using covalent tethering approach to identify inhibitors preferentially targeting inactive conformation; targets for development of anticancer drugs
04/10/2007US7202032 Diagnosing viral food poisioning using genetically engineered viral RNA sequences
04/10/2007US7202031 Co-amplifying a set of at least three microsatellite loci of genomic DNA, containing one mononucleotide repeat locus and atleast two tetranucleotide repeat loci, from the sample of genomic DNA in a multiplex amplification reaction
04/10/2007US7202029 Nucleic acids encoding human TANGO 195
04/10/2007US7202027 Nucleic acid molecules for detecting bacteria and phylogenetic units of bacteria
04/10/2007US7202025 Control of gene expression
04/10/2007US7202024 Detecting modulators of apoptosis; provide a cell coing preferenial gene, incubate with modulator, detect adjustment in gene expression, adjustment in gene expression indicates modulatior
04/10/2007US7202021 Antibody for use in the detection of viral protein; for use in diagnosis of creutzfeldt-jakob disease
04/10/2007US7201911 Cloned genomes of infectious hepatitis C viruses and uses thereof
04/10/2007US7201909 Genetic engineering; genome dsegment containing identifying phenotype; generation immunology response
04/10/2007US7201908 Modified HPV E6 and E7 genes and proteins useful for vaccination
04/10/2007US7201905 Fusion protein, comprising a receptor-antagonizing domain (such as prolactin receptor antagonist) and a positive immunomodulator domain (such as an interleukin); combines apoptosis induction and immunotherapy
04/10/2007US7201899 Materials and methods for management of hyperacute rejection in human xenotransplantation
04/10/2007US7201898 Methods and compounds for controlled release of recombinant parvovirus vectors
04/10/2007US7201895 High-affinity antagonists of ELR-CXC chemokines
04/10/2007CA2400361C Immortalized vascular pericyte line
04/10/2007CA2354377C A method for manufacturing glycoproteins having human-type glycosylation
04/10/2007CA2319668C Human tsc403 gene and human ing1l gene
04/10/2007CA2316808C Transgenic rabbit that expresses a functional human lipoprotein (a)
04/10/2007CA2311599C Transgenic non-human mammals with an oncogenic mutant of raf gene 1
04/10/2007CA2309755C Hormone-dependent forms of the adeno-associated virus, rep proteins, dna sequences coding for them, vectors containing them, and regulatory methods of their intracellular activity
04/10/2007CA2267647C Esterases, dna encoding therefor and vectors and host cells incorporating same
04/10/2007CA2254931C Human monoclonal antibodies to the hepatitis b surface antigen
04/10/2007CA2242382C Compositions and methods for mediating cell cycle progression
04/10/2007CA2237539C Integrally attached and operable multiple reaction vessels
04/10/2007CA2236001C Biologically active eph family ligands
04/10/2007CA2209172C Murine monoclonal anti-idiotype antibody 3h1
04/10/2007CA2199131C Retroviral vector hybrids and the use thereof for gene transfer
04/10/2007CA2173834C Monoclonal antibodies to thymidine kinase isozymes
04/10/2007CA2171289C Il8 inhibitors
04/10/2007CA2154023C Recombinant infectious non-segmented negative strand rna virus
04/10/2007CA2150816C Monoclonal antibodies directed against the microtubule- associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and theirapplications
04/10/2007CA2125174C Novel polypeptides for promoting cell attachment
04/10/2007CA2121599C Monoclonal antibodies directed against the microtubule-associated protein tau
04/10/2007CA2100674C Chilling resistant plants and their production
04/10/2007CA2084351C P0438 - a new calcium-regulated promoter
04/10/2007CA2071016C Method for detecting bovine diarrhoea virus infection nucleotide sequence encoding a protein induced by this virus infection and recombinant proteins and antigens relating thereto
04/10/2007CA2035369C Modification of plant metabolism
04/05/2007WO2007038788A2 Small interfering rnas as non-specific drugs
04/05/2007WO2007038746A2 Versatile vectors for expression of foreign proteins in photosynthetic bacteria
04/05/2007WO2007038704A1 Peptide tags for the expression and purification of bioactive peptides
04/05/2007WO2007038345A2 F-box protein targeted plant oil production
04/05/2007WO2007038316A2 Human cytomegalovirus latency promoting genes, related virus variants and methods of use
04/05/2007WO2007038276A2 Dna modular cloning vector plasmids and methods for their use
04/05/2007WO2007038264A2 Gapr-1 methods
04/05/2007WO2007038130A2 Improved strains for the production of organic acids
04/05/2007WO2007037765A1 Novel nucleolar gtpases and method for controlling proliferation of cells
04/05/2007WO2007037560A1 Therapeutic or diagnostic application of sgk2 gene
04/05/2007WO2007037555A1 Therapeutic or diagnostic application of dusp15 gene
04/05/2007WO2007037550A1 Therapeutic or diagnostic application of tsta3 gene
04/05/2007WO2007037538A1 Therapeutic or diagnostic application of spo11 gene
04/05/2007WO2007037533A1 Therapeutic or diagnostic application of ppp1r3d gene
04/05/2007WO2007037532A1 Therapeutic or diagnostic application of srms gene
04/05/2007WO2007037509A1 Nucleic acid extraction method
04/05/2007WO2007037482A1 Kit and method for use in the detection of protein-protein interaction in eukaryotic cell
04/05/2007WO2007037473A1 Method of inhibiting cell migration and cell migration inhibitor
04/05/2007WO2007037444A1 Vector for delivering target substance into nucleus or cell
04/05/2007WO2007037430A1 T-cell adhesion molecule and antibody directed against the molecule
04/05/2007WO2007037429A1 Novel recombinant human hepatitis c virus-like particle and method for producing the same
04/05/2007WO2007037428A1 High production system for infectious hepatitis c virus particle
04/05/2007WO2007037354A1 Novel acid-resistant mutant s-hydroxynitrile lyase
04/05/2007WO2007037341A1 Method for specifically detecting test substance using photocurrent, and electrode, measuring cell and measuring device for use therefor
04/05/2007WO2007037315A1 Novel nano structure and method for construction thereof
04/05/2007WO2007037301A1 Process for producing useful substance
04/05/2007WO2007037300A1 Process for producing useful substance
04/05/2007WO2007037299A1 Substance inhibiting the expression of hb24 or the transcriptional regulatory activity thereof, use of the same and method of screening the substance
04/05/2007WO2007037282A1 Method of forming autoaggregate on microparticle and method of detecting target analyte
04/05/2007WO2007037273A1 Introduction of substance into cell by using nanoparticle having cell membrane-permeable peptide displayed thereon
04/05/2007WO2007037270A1 Method of detecting mutation in tnp1 gene
04/05/2007WO2007037245A1 Polypeptide having anti-angiogenic activity
04/05/2007WO2007037133A1 Method for evaluation of compound capable of acting on plk3
04/05/2007WO2007036945A2 Hepatocyte growth factor receptor splice variants and methods of using same
04/05/2007WO2007036638A1 Cd4+ t survivin epitopes and uses thereof
04/05/2007WO2007036564A2 Method and formulation for the extraction of nucleic acids from any complex starting materials
04/05/2007WO2007036366A2 Modification of rna, producing an increased transcript stability and translation efficiency
04/05/2007WO2007036045A1 Method of modulating flowering time and shoot branching
04/05/2007WO2007036021A1 Blood-brain barrier epitopes and uses thereof
04/05/2007WO2007021944A3 In vitro recombination method
04/05/2007WO2007019442A3 Polypeptides having beta-glucosidase activity and polynucleotides encoding same
04/05/2007WO2007013882A9 In vitro model for hepatitis c virion production
04/05/2007WO2007011670A3 Heterodimeric four helix bundle cytokines
04/05/2007WO2007011210A3 Parechovirus, vaccines, medicaments and diagnostic kits
04/05/2007WO2007007154A3 Novel phage display technologies
04/05/2007WO2006135654A3 Polymer evolution via templated synthesis related applications
04/05/2007WO2006134198A3 Isolation and characterisation of the csb3-1 mutant of arabidopsis thaliana and use thereof as a regulator of resistance in plants to diseases caused by biotrophic pathogens
04/05/2007WO2006119983A3 Genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
04/05/2007WO2006117600A3 Double-stranded synthetic oligonucleotides useful for inducing apoptosis of osteoclasts for the treatment of osteopenic pathologies
04/05/2007WO2006110689A3 Method of increasing the function of an aav vector
04/05/2007WO2006110594A3 Sema4d in cancer diagnosis, detection and treatment
04/05/2007WO2006110292A3 Temperature-triggered immobilization and purification of antibodies
04/05/2007WO2006106435A3 Fusion protein comprising a hiv nef double mutant and its use therapy
04/05/2007WO2006105946A3 Methods and means for removal of a selected dna sequence